ロード中...
Biosimilars in the management of chronic inflammatory diseases: The Dutch experience
These days, the use of biosimilars for the treatment of bio-naive patients is well established. However, the transition of patients being treated with a bio-originator to its biosimilar is still a topic of discussion. The main issue is which approach to use when initiating the non-medical transition...
保存先:
| 出版年: | Mediterr J Rheumatol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Mediterranean Journal of Rheumatology (MJR)
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7280871/ https://ncbi.nlm.nih.gov/pubmed/32524082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31138/mjr.30.1.76 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|